ATAI vs STT · rev $4.1M vs P/E 17, rev $7.84B
ATAI Life Sciences BV (ATAI) versus State Street Corp (STT) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
State Street Corp (STT) is a asset management company listed on US.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
Latest reported STT revenue for 2026-06-30 was $7.84B. Net income was $1.85B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
ATAI currently screens at market cap $555.8M. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Not investment advice. Open the ATAI and STT stock pages for the full models.
Not investment advice.